Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Spyre Therapeutics has the lowest figure of the 52 pharmaceutical companies ranked by revenue, at SEK 0, followed by Praxis Precision Medicines (SEK 0) and Dianthus Therapeutics (SEK 20.7M). Figures as of 18 Nov 2026, 22:08 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- Lowest
- Spyre TherapeuticsSEK 0
- Median
- SEK 32.5B
- Combined market value
- SEK 51.35T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Spyre TherapeuticsSYRE · Health Care | SEK 0 | SEK 97.8B | SEK 1,029.81 | 8.15% up | 286% up | ||
| 2 | Praxis Precision MedicinesPRAX · Health Care | SEK 0 | SEK 86.6B | SEK 3,097.65 | 0.04% up | 61% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | SEK 20.7M | SEK 48B | SEK 852.39 | 3.45% down | 113% up | ||
| 4 | Roivant SciencesROIV · Health Care | SEK 83.8M | SEK 284.8B | SEK 393.11 | 0.05% up | 90% up | ||
| 5 | Protagonist TherapeuticsPTGX · Health Care | SEK 467.1M | SEK 84.2B | SEK 1,290.66 | 2.00% up | 46% up | ||
| 6 | CytokineticsCYTK · Health Care | SEK 893.6M | SEK 72.6B | SEK 520.89 | 0.64% down | 20% down | ||
| 7 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 1.9B | SEK 83.8B | SEK 1,208.25 | 2.08% up | 13% up | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | SEK 2.7B | SEK 60.6B | SEK 3,031.88 | 1.67% up | 43% up | ||
| 9 | Travere TherapeuticsTVTX · Health Care | SEK 5B | SEK 48.9B | SEK 509.93 | 1.68% down | 44% up | ||
| 10 | BridgeBio PharmaBBIO · Health Care | SEK 5.1B | SEK 154.2B | SEK 791.80 | 1.58% up | 17% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | SEK 5.3B | SEK 61.3B | SEK 938.77 | 0.59% up | 31% up | ||
| 12 | InsmedINSM · Health Care | SEK 6.2B | SEK 266.8B | SEK 1,215.96 | 1.69% down | 40% down | ||
| 13 | TG TherapeuticsTGTX · Health Care | SEK 6.3B | SEK 101.4B | SEK 671.11 | 5.44% up | 107% up | ||
| 14 | Axsome TherapeuticsAXSM · Health Care | SEK 6.5B | SEK 71.5B | SEK 1,360.09 | 1.43% down | 7% down | ||
| 15 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 6.9B | SEK 75.8B | SEK 964.75 | 0.06% down | 126% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | SEK 7.7B | SEK 75.3B | SEK 688.06 | 3.25% down | 8% down | ||
| 17 | Ascendis PharmaASND · Health Care | SEK 8.1B | SEK 180B | SEK 2,743.83 | 0.32% down | 28% up | ||
| 18 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 8.4B | SEK 61.9B | SEK 437.56 | 0.28% up | 10% up | ||
| 19 | Ionis PharmaceuticalsIONS · Health Care | SEK 9.6B | SEK 46.3B | SEK 278.01 | 1.59% up | 64% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 9.7B | SEK 93.9B | SEK 4,040.48 | 5.67% down | 24% down | ||
| 21 | Legend BiotechLEGN · Health Care | SEK 10.4B | SEK 32B | SEK 164.94 | 0.87% up | 42% down | ||
| 22 | AlkermesALKS · Health Care | SEK 15B | SEK 79.9B | SEK 475.52 | 3.08% up | 58% up | ||
| 23 | PTC TherapeuticsPTCT · Health Care | SEK 17.6B | SEK 51.1B | SEK 611.33 | 0.22% down | 20% down | ||
| 24 | Royalty PharmaRPRX · Health Care | SEK 24.1B | SEK 400.8B | SEK 697.00 | 0.01% down | 78% up | ||
| 25 | Amneal PharmaceuticalsAMRX · Health Care | SEK 30.6B | SEK 77.4B | SEK 222.08 | 3.60% up | 83% up | ||
| 26 | United TherapeuticsUTHR · Health Care | SEK 32.3B | SEK 249.6B | SEK 5,859.95 | 1.16% down | 23% up | ||
| 27 | BioMarin PharmaceuticalBMRN · Health Care | SEK 32.7B | SEK 120.8B | SEK 623.51 | 4.99% up | 11% up | ||
| 28 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 36.3B | SEK 126.8B | SEK 152.05 | 1.28% up | 5% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | SEK 37.7B | SEK 203.1B | SEK 1,516.40 | 4.54% down | 66% down | ||
| 30 | GenmabGMAB · Health Care | SEK 37.8B | SEK 319B | SEK 517.34 | 1.91% down | 70% up | ||
| 31 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 43.3B | SEK 161.4B | SEK 2,514.85 | 2.93% up | 37% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | SEK 47.9B | SEK 135.5B | SEK 271.00 | 3.29% up | 20% up | ||
| 33 | BeOne MedicinesONC · Health Care | SEK 54.2B | SEK 467.9B | SEK 4,096.51 | 2.34% down | 17% up | ||
| 34 | GrifolsGRFS · Health Care | SEK 84.7B | SEK 58.5B | SEK 85.97 | 1.85% down | 1% up | ||
| 35 | ZoetisZTS · Health Care | SEK 96.1B | SEK 352.9B | SEK 868.53 | 2.50% up | 29% down | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | SEK 121.8B | SEK 1.38T | SEK 5,444.92 | 0.42% up | 27% up | ||
| 37 | ViatrisVTRS · Health Care | SEK 145.1B | SEK 236B | SEK 205.84 | 0.83% down | 96% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | SEK 145.6B | SEK 992.8B | SEK 9,597.05 | 1.28% down | 36% up | ||
| 39 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 175.2B | SEK 500.1B | SEK 428.63 | 0.92% down | 74% up | ||
| 40 | Takeda PharmaceuticalTAK · Health Care | SEK 286.4B | SEK 689.7B | SEK 215.89 | 1.71% down | 54% up | ||
| 41 | GSKGSK · Health Care | SEK 440.1B | SEK 988.4B | SEK 493.08 | 1.34% down | 6% up | ||
| 42 | Abbott LaboratoriesABT · Health Care | SEK 449.9B | SEK 1.84T | SEK 1,060.46 | 0.22% down | 17% down | ||
| 43 | Novo NordiskNVO · Health Care | SEK 465.5B | SEK 1.76T | SEK 400.21 | 3.12% down | 17% down | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | SEK 489.2B | SEK 1.24T | SEK 604.53 | 2.92% down | 34% up | ||
| 45 | SanofiSNY · Health Care | SEK 491.3B | SEK 1.15T | SEK 478.26 | 0.86% down | 4% down | ||
| 46 | NovartisNVS · Health Care | SEK 553.5B | SEK 2.98T | SEK 1,575.37 | 2.46% down | 25% up | ||
| 47 | AstraZenecaAZN · Health Care | SEK 596.2B | SEK 2.81T | SEK 1,814.40 | 1.93% down | 2% up | ||
| 48 | AbbVieABBV · Health Care | SEK 620.8B | SEK 5.13T | SEK 2,902.98 | 2.33% down | 26% up | ||
| 49 | PfizerPFE · Health Care | SEK 635.2B | SEK 1.62T | SEK 284.81 | 1.44% down | 14% up | ||
| 50 | Merck & CoMRK · Health Care | SEK 659.9B | SEK 3.45T | SEK 1,398.46 | 3.90% down | 51% up | ||
| 51 | Eli LillyLLY · Health Care | SEK 661.6B | SEK 12.5T | SEK 14,034.80 | 2.32% down | 35% up | ||
| 52 | Johnson & JohnsonJNJ · Health Care | SEK 956.1B | SEK 6.66T | SEK 2,767.88 | 2.15% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1499 SEK). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies have the lowest revenue?
Spyre Therapeutics (SEK 0), Praxis Precision Medicines (SEK 0) and Dianthus Therapeutics (SEK 20.7M) have the lowest revenue of the 52 pharmaceutical companies ranked here as of 18 Nov 2026, 22:08 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of SEK 51.35T as of 18 Nov 2026, 22:08 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.